These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39224912)

  • 1. Intradermal Injection of a Thermoresponsive Polymeric Dexamethasone Prodrug (ProGel-Dex) Ameliorate Dermatitis in an Imiquimod (IMQ)-Induced Psoriasis-like Mouse Model.
    Jiang H; Fu X; Zhao G; Du X; Georgesen C; Thiele GM; Goldring SR; Wang D
    Mol Pharm; 2024 Oct; 21(10):4995-5004. PubMed ID: 39224912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermoresponsive polymeric dexamethasone prodrug for arthritis pain.
    Zhao G; Ren R; Wei X; Jia Z; Chen N; Sun Y; Zhao Z; Lele SM; Zhong HA; Goldring MB; Goldring SR; Wang D
    J Control Release; 2021 Nov; 339():484-497. PubMed ID: 34653564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose thermoresponsive dexamethasone prodrug completely mitigates joint pain for 15 weeks in a murine model of osteoarthritis.
    Chen N; Wei X; Zhao G; Jia Z; Fu X; Jiang H; Xu X; Zhao Z; Singh P; Lessard S; Otero M; Goldring MB; Goldring SR; Wang D
    Nanomedicine; 2024 Apr; 57():102735. PubMed ID: 38295913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of formulation parameters that affect the analgesic efficacy of ProGel-Dex - A thermoresponsive polymeric dexamethasone prodrug for chronic arthritis pain relief.
    Wei X; Zhao G; Chen N; Xu X; Jiang H; Tran D; Glissmeyer E; Goldring MB; Goldring SR; Wang D
    Nanomedicine; 2024 Nov; 62():102782. PubMed ID: 39179013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Evaluation of the Therapeutic Efficacy and Side Effects of a Macromolecular Dexamethasone Prodrug in the Collagen-Induced Arthritis Mouse Model.
    Quan L; Zhang Y; Dusad A; Ren K; Purdue PE; Goldring SR; Wang D
    Pharm Res; 2016 Jan; 33(1):186-93. PubMed ID: 26286188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermoresponsive Polymeric Hydromorphone Prodrug Provides Sustained Local Analgesia without Apparent Adverse Effects.
    Jia Z; Wei X; Chen N; Xu X; Zhao G; Fu X; Wang H; Goldring MB; Goldring SR; Wang D
    Mol Pharm; 2024 Apr; 21(4):1838-1847. PubMed ID: 38413029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Dose-Escalation Study of ZSJ-0228, a Polymeric Dexamethasone Prodrug, in the Treatment of Murine Lupus Nephritis.
    Zhao Z; Xu X; Jiang H; Foster KW; Jia Z; Wei X; Chen N; Goldring SR; Crow MK; Wang D
    Mol Pharm; 2021 Nov; 18(11):4188-4197. PubMed ID: 34569234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis.
    Chan TC; Lee MS; Huang WC; Chang WY; Krueger JG; Tsai TF
    Biomed Pharmacother; 2021 Sep; 141():111950. PubMed ID: 34328106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.
    Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y
    Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Micheli L; Vasarri M; Degl'Innocenti D; Di Cesare Mannelli L; Ghelardini C; Emiliano A; Verdelli A; Caproni M; Barletta E
    Mar Drugs; 2024 Jun; 22(7):. PubMed ID: 39057409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macromolecular prodrug of dexamethasone prevents particle-induced peri-implant osteolysis with reduced systemic side effects.
    Ren K; Dusad A; Yuan F; Yuan H; Purdue PE; Fehringer EV; Garvin KL; Goldring SR; Wang D
    J Control Release; 2014 Feb; 175():1-9. PubMed ID: 24326124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone prodrug treatment prevents nephritis in lupus-prone (NZB × NZW)F1 mice without causing systemic side effects.
    Yuan F; Nelson RK; Tabor DE; Zhang Y; Akhter MP; Gould KA; Wang D
    Arthritis Rheum; 2012 Dec; 64(12):4029-39. PubMed ID: 22886616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
    Feng H; Wu R; Zhang S; Kong Y; Liu Z; Wu H; Wang H; Su Y; Zhao M; Lu Q
    J Dermatol; 2020 Feb; 47(2):147-154. PubMed ID: 31773789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorative effects of topical ramelteon on imiquimod-induced psoriasiform inflammation in mice.
    Khafaji AWM; Al-Zubaidy AAK; Farhood IG; Salman HR
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):6231-6248. PubMed ID: 38446218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments.
    Smajlović A; Haverić A; Alić A; Hadžić M; Smajlović A; Mujezinović I; Lojo-Kadrić N; Ramić J; Elez-Burnjaković N; Haverić S; Pojskić L
    Mol Biol Rep; 2021 May; 48(5):4295-4303. PubMed ID: 34097205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unconjugated bilirubin and its derivative ameliorate IMQ-induced psoriasis-like skin inflammation in mice by inhibiting MMP9 and MAPK pathway.
    Bharatha M; Nandana MB; Praveen R; Nayaka S; Velmurugan D; Vishwanath BS; Rajaiah R
    Int Immunopharmacol; 2024 Mar; 130():111679. PubMed ID: 38377853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
    Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
    Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway.
    Shi Q; He Q; Chen W; Long J; Zhang B
    J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Application of BMS-509744, a Selective Inhibitor of Interleukin-2-Inducible T Cell Kinase, Ameliorates Imiquimod-Induced Skin Inflammation in Mice.
    Otake S; Otsubaki T; Uesato N; Ueda Y; Murayama T; Hayashi M
    Biol Pharm Bull; 2021 Apr; 44(4):528-534. PubMed ID: 33473072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of
    Emami Z; Shobeiri SS; Khorrami R; Haghnavaz N; Rezaee MA; Moghadam M; Pordel S; Sankian M
    Mediators Inflamm; 2024; 2024():5821996. PubMed ID: 39045230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.